Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2026
FROM THE WIRE · PRNEWSWIRE.COM
Net revenues of $207.6 million for the three months ended September 30, 2026 GAAP net income of $37.8 million, or $0.87 per share, for the third quarter Adjusted non-GAAP net income of $49.3 million, or $1.14 per share, for the third quarter Company to hold a conference call…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishGAAP and adjusted earnings per share reported, relevant for the pharma stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Net revenues were $207.6 million for the three months ended September 30, 2026.
- 02GAAP net income was $37.8 million, or $0.87 per share.
- 03Adjusted non-GAAP net income was $49.3 million, or $1.14 per share.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets